AXP vs HALO · P/E 20, rev $21.73B vs P/E 15, rev $857.7M
American Express Company (AXP) versus Halozyme Therapeutics Inc (HALO) — a side-by-side from cached financials, not a winner call.
American Express Company (AXP) is a credit services company listed on US. It is led by Stephen Joseph Squeri.
Halozyme Therapeutics Inc (HALO) is a biotechnology company listed on US.
Latest reported AXP revenue for 2026-06-30 was $21.73B. Net income was $6.08B. AXP currently screens at market cap $215.94B and trailing P/E 19.8.
Latest reported HALO revenue for 2026-06-30 was $857.7M. Net income was $380.0M. HALO currently screens at market cap $7.10B and trailing P/E 15.3.
AXP currently screens at market cap $215.94B and trailing P/E 19.8. HALO currently screens at market cap $7.10B and trailing P/E 15.3.
Not investment advice. Open the AXP and HALO stock pages for the full models.
Not investment advice.